Scarica l'app Stockscreener
5.81
4.60%
-0.28
Dopo l'orario di chiusura:
5.87
0.06
+1.03%
Entrada Therapeutics Inc Azioni (TRDA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
90.51%
1.95
|
20.56 | 19.57 | 94.69 | 59.12 |
Operating Expenses
|
15.23%
48.80
|
42.35 | 41.23 | 41.27 | 38.01 |
| Benefits Costs and Expenses |
100.00%
-
|
37.91 | - | - | - |
| Costs And Expenses |
28.73%
48.80
|
37.91 | 41.23 | 41.27 | 38.01 |
| Operating Income/Loss |
115.00%
-46.85
|
-21.79 | -21.66 | 53.42 | 21.11 |
| Income/Loss From Continuing Operations Before Tax |
111.24%
1.95
|
-17.35 | 19.57 | 55.03 | 23.50 |
| Income Tax Expense/Benefit |
0.178
|
- | -1.86 | 2.758 | 1.831 |
| Income/Loss From Continuing Operations After Tax |
148.45%
-43.10
|
-17.35 | -14.03 | 55.03 | 23.50 |
|
Net Income/Loss
|
148.45%
-43.10
|
-17.35 | -14.03 | 55.03 | 23.50 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.65%
41.34
|
41.07 | 40.63 | 34.18 | 33.50 |
| Diluted Average Shares |
0.65%
41.34
|
41.07 | 40.63 | 35.51 | 34.79 |
| Basic Earnings Per Share |
147.62%
-1.04
|
-0.42 | -0.35 | 1.61 | 0.70 |
| Diluted Earnings Per Share |
147.62%
-1.04
|
-0.42 | -0.35 | 1.55 | 0.68 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):